Patent · US Active

Nitric oxide scavengers

US9511053B2 · kind B2 · utility

0Cited by

10References

9Claims

0Family size

Assignees

Baxter International Inc. · US
Baxter Healthcare SA · CH

Inventors

Sujatha Karoor · Lake Forest, US
Ton That Hai · Round Lake, US
Cong Jiang · Gurnee, US
Paul Sanders · Greendale, US
Cliff Holmes · Glenview, US

Key dates

Filing date	Dec 30, 2015
Grant date	Dec 6, 2016
Priority date	—
Expiry date	Dec 30, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Therapeutic compositions capable of removing excess nitric oxide are provided. The therapeutic compositions include nitronyl nitroxide monoradicals, B12 derivatives, flavonoid derivatives, the like and combinations thereof. The therapeutic compositions can be utilized in a number of suitable applications, such as to prevent or treat intradialytic hypotension during dialysis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.